Mobile Devices
Technology
Medical

Teladoc Health

$61.31
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.31 (2.19%) Today
+$0.11 (0.18%) After Hours

Why Robinhood?

You can buy or sell Teladoc Health and other stocks, options, ETFs, and crypto commission-free!

About

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. Read More The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.

Employees
2,000
Headquarters
Purchase, New York
Founded
2002
Market Cap
4.37B
Price-Earnings Ratio
Dividend Yield
0.00
Average Volume
1.57M
High Today
$61.30
Low Today
$59.65
Open Price
$60.51
Volume
241.40K
52 Week High
$89.05
52 Week Low
$42.08

Collections

Mobile Devices
Technology
Medical
Electronics
Health
Healthcare
Software Service
2015 IPO

News

Seeking AlphaMay 21

Teladoc Health Looks Pretty Interesting

There are some latent concerns and there is a big short position, which makes the shares quite volatile. Cash flow concerns are dwindling, as the business model does contain a fair amount of leverage. The company has multiple growth avenues in front of it, like Medicare Advantage and overseas growth. Teladoc is a big player in the rapidly rising virtual care market, which is still in the early innings. With increased electronic communication channels come all sorts of opportunities for new business mode...

891
Seeking AlphaMay 21

Why Teladoc Could Break Out

Teladoc (TDOC) enjoyed much of last year on an uptrend that led to the stock peaking at around $89. Yet, the end of the year 2018 selling took the stock back to the $40s. In the last two quarters, strong back-to-back earnings reports alleviated valuation concerns for TDOC stock.

536
Seeking AlphaMay 16

Teladoc: Significant Near-Term Contract Risk After NCQA Corrective Action Debacle

Why would naturally risk-averse insurers want to do business with Teladoc when it is the only major telehealth company on a NCQA “Corrective Action Status”? Can investors trust the CEO who claimed Teladoc’s relationship with Aetna is strong when just two weeks ago he claimed that NCQA’s delay was “much ado about nothing”? Teladoc clearly once believed its NCQA score mattered - it has touted its NCQA "perfect score" in marketing materials but has already begun to roll back this claim (see article). Indust...

453

Earnings

-$0.54
-$0.47
-$0.41
-$0.34
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Jul 31, After Hours

Popular Stocks

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.